Clinical trialNCT00968669CompletedPhase 2Interventional

A Study to Evaluate the Effectiveness and Safety of MEDI-528 in Adults

SponsorMedImmune LLCEnrollment329Asthma

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

To study the effectiveness and safety of multiple-doses of MEDI-528 on asthma control in adult participants with uncontrolled, moderate-to-severe, persistent asthma.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Chad Oh, M.D.
MedImmune LLC
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

57 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina

Research Site
Buenos Aire, Buenos Aires F.D., Argentina
Research Site
Ciudad Autonoma Bs As, Buenos Aires F.D., Argentina
Research Site
Rosario, Santa Fe Province, Argentina
Research Site
San Miguel de Tucumán, Tucumán Province, Argentina
Research Site
Buenos Aires, Argentina
Research Site
Ciudad de Buenos Aire, Argentina

Brazil

Research Site
Porto Alegre, Rio Grande do Sul, Brazil
Research Site
Porto Alegre, Rio Grande do Sul, Brazil
Research Site
Florianópolis, Santa Catarina, Brazil
Research Site
Santo André, Brazil
Research Site
São Paulo, Brazil

Canada

Research Site
Calgary, Alberta, Canada
Research Site
Edmonton, Alberta, Canada
Research Site
Vancouver, British Columbia, Canada
Research Site
Mississauga, Ontario, Canada
Research Site
Ottawa, Ontario, Canada
Research Site
Montreal, Quebec, Canada
Research Site
Québec, Quebec, Canada
Research Site
Québec, Quebec, Canada

Colombia

Research Site
Bogota, Cundinamarca, Colombia
Research Site
Bogota DC, Cundinamarca, Colombia
Research Site
Bogotá D.C., Cundinamarca, Colombia

Costa Rica

Research Site
San Francisco de Dos Ríos, Provincia de San José, Costa Rica

Panama

Research Site
Panama City, Panama

Peru

Research Site
Lima, Lima Province, Peru
Research Site
Lima, Lima Province, Peru
Research Site
Lima, Lima Province, Peru
Research Site
Jesus Maria, Lima region, Peru

Philippines

Research Site
Lipa City, Batangas, Philippines
Research Site
Iloilo City, Iloilo, Philippines
Research Site
Quezon City, National Capital Region, Philippines

Taiwan

Research Site
Kaohsiung City, Taiwan
Research Site
Taoyuan, Taiwan

United States

Research Site
Pell City, Alabama, United States
Research Site
Los Angeles, California, United States
Research Site
Sacramento, California, United States
Research Site
San Diego, California, United States
Research Site
Centennial, Colorado, United States
Research Site
Colarado Springs, Colorado, United States
Research Site
Thornton, Colorado, United States

17 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

MEDI528 100 mgMEDI528 30 mgMEDI528 300 mg

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Dec 2009
Primary completion: 30 Nov 2011
Completion: 31 Jan 2012
Last update posted: 4 Jun 2014
Registered enrollment: 329
Registry id: NCT00968669

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.